The Role of Arginase 1 in Post-Stroke Immunosuppression and Ischemic Stroke Severity

Translational Stroke Research

Volumn 7, Issue 2, 2016, Pages 103-110

  Petrone, Ashley B ^a   O’Connell, Grant C ^a   Regier, Michael D ^a   Chantler, Paul D ^a,b   Simpkins, James W ^a,b   Barr, Taura L ^a,c  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

Arginase; Immune system; Neutrophil lymphocyte ratio; Stroke

Indexed keywords

ARGINASE 1; CALGRANULIN C; GELATINASE B; PROTEIN; PROTEIN MD 2; ARGINASE; ARGINASE I, HUMAN; COLLAGENASE; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA; S100A12 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EXPLANATORY VARIABLE; FEMALE; GENE; GENE EXPRESSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE DIFFERENTIAL COUNT; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; VARIMAX ROTATION; BLOOD; COMPLICATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; NEUTROPHIL; PATHOLOGY; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; STROKE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ARGINASE; BRAIN ISCHEMIA; COLLAGENASES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PRINCIPAL COMPONENT ANALYSIS; REGRESSION ANALYSIS; RNA, MESSENGER; S100A12 PROTEIN; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84959540199     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-015-0431-9     Document Type: Article

References (20)

1. Vogelgesang A, Dressel A. Immunological consequences of ischemic stroke: immunosuppression and autoimmunity. J Neuroimmunol. 2011;231(1–2):105–10.
2. Kamel H, Iadecola C. Brain-immune interactions and ischemic stroke: clinical implications. Arch Neurol. 2012;69(5):576–81.
3. Shichita T, Sakaguchi R, Suzuki M, Yoshimura A. Post-ischemic inflammation in the brain. Front Immunol. 2012;3:132.
4. Offner H, Vandenbark AA, Hurn PD. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience. 2009;158(3):1098–111.
5. Tang Y, Xu H, Du X, Lit L, Walker W, Lu A, et al. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. 2006;26(8):1089–102.
6. Barr TL, Conley Y, Ding J, Dillman A, Warach S, Singleton A, et al. Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling. Neurology. 2010;75(11):1009–14.
7. Tokgoz S, Kayrak M, Akpinar Z, Seyithanoglu A, Guney F, Yuruten B. Neutrophil lymphocyte ratio as a predictor of stroke. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc. 2013;22(7):1169–74.
8. Brooks SD, Spears C, Cummings C, VanGilder RL, Stinehart KR, Gutmann L, et al. Admission neutrophil-lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy. J Neurointerv Surg. 2014;6(8):578–83.
9. Caldwell RB, Toque HA, Narayanan SP, Caldwell RW. Arginase: an old enzyme with new tricks. Trends Pharmacol Sci. 2015;36(6):395–405.
10. Munder M. Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol. 2009;158(3):638–51.
11. Sippel TR, Shimizu T, Strnad F, Traystman RJ, Herson PS, Waziri A. Arginase I release from activated neutrophils induces peripheral immunosuppression in a murine model of stroke. J Cereb Blood Flow Metab. 2015;35(10):1657–63.
12. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172(5):2731–8.
13. Stamova BS, Apperson M, Walker WL, Tian Y, Xu H, Adamczy P, et al. Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood. BMC Med Genet. 2009;2:49.
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001;25(4):402–8.
15. Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–60.
16. Kidwell CS, Warach S. Acute ischemic cerebrovascular syndrome: diagnostic criteria. Stroke J Cereb Circ. 2003;34(12):2995–8.
17. Woo D, Broderick JP, Kothari RU, Lu M, Brott T, Lyden PD, et al. Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group. Stroke J Cereb Circ. 1999;30(11):2355–9.
18. Moschovakis GL, Forster R. Multifaceted activities of CCR7 regulate T-cell homeostasis in health and disease. Eur J Immunol. 2012;42(8):1949–55.
19. Ponnappan S, Ponnappan U. Aging and immune function: molecular mechanisms to interventions. Antioxid Redox Signal. 2011;14(8):1551–85.
20. Tratsiakovich Y, Yang J, Gonon AT, Sjoquist PO, Pernow J. Arginase as a target for treatment of myocardial ischemia-reperfusion injury. Eur J Pharmacol. 2013;720(1–3):121–3.